Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0598934 (tumor growth)
 58,965 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Report on the application of a dinitrochlorobenzene ointment of 61 postoperative melanoma patients exhibiting clinical stages I and II. After contact sensitization the erythemogenic threshold concentrations of DNCB were mostly found in the range of 0,05% and 0,1%. Patients with reactions at low concentrations of 0,01% and 0,05% DNCB were in the mean 8 years younger than those with reactions at 0,1% and 0,5%, but no connection to different stages of malignant melanoma could be evaluated. 3 melanoma patients suffering from skin metastases were treated by epifocal DNCB-application. One of them became clinically tumor free since more than 1 year, whereas the two other exhibiting multicentric and/or profound tumor growth did not respond. In a 82-year-old wife a superficial lentigo maligna melanoma disappeared by DNCB-application. In none of the 61 cases we observed a "tumor enhancement" after immunoprophylaxis or adjuvant immunotherapy with DNCB. The DNCB-method in malignant melanoma is yet in the experimental stage and is not recommended for general use in practice.
 ...
PMID:[Adjuvant DNCB immunotherapy in malignant melanoma]. 47 40

We tried to confirm the anamnestical data of patients with malignant melanoma with the aid of private photos. The statement of the patients that a "birth-mark" was present before the development of the malignant melanoma could nearly always be corroborated by the photographs. The patients' statements that the tumor had developed in uninvolved epidermis in a relatively short time proved to be correct in many cases. In some cases, however, the "birth-marks" could be detected on the photographs at a time, when these marks were not yet recognized by the patients. According to the statement of the patients and the results of the pictures, lentigo maligna-melanoma, superficial spreading melanoma, and nodular melanoma can originate from a pre-existing pigmented spot or can develop in a relatively short time in uninvolved epidermis. In most cases of lentigo maligna-melanoma a long history and a slow tumor growth is stated. Generally the development of nodular melanoma is extremely short. In cases of superficial spreading melanoma the time of tumor growth was reported to be a few month or up to one or two years. In some cases, however, a much slower development of the tumor could be detected with the aid of the photographs.
 ...
PMID:[Development of malignant melanomas on preexisting pigmentary lesions. Control of anamnestic data based on patients private photographic series]. 59 24

Sixty-one xeroderma pigmentosum (XP) patients living in the Federal Republic of Germany were investigated. Clinical symptoms were correlated with DNA repair parameters measured in fibroblasts grown from skin biopsies. Classification according to the international complementation groups revealed that of the 61 patients 3 belonged to group A, 26 to group C, 16 to group D, 3 to group E, and 2 to group F; 11 were of the XP variant type. A striking clinical aspect was the frequency of histogenetically different skin tumors varying from one XP complementation group to the other: squamous and basal cell carcinomas predominated in XP group C; lentigo maligna melanomas were most frequent in group D; basal cell carcinomas occurred preferentially in group E and XP variants. Three DNA repair parameters were determined for 46 fibroblast strains: colony-forming ability (D0); DNA repair synthesis (G0); and DNA-incising capacity (E0). Dose-response experiments with up to 13 dose levels were performed throughout to achieve sufficient experimental accuracy. DNA-damaging treatments included UV light, the "UV-like" carcinogen N-acetoxy-2-acetylaminofluorene, and the alkylating carcinogens methyl methanesulfonate and N-methyl-N-nitrosourea. Comparison of clinical signs and repair data was made on the basis of D0, G0, and E0 values of both individual cell strains and weighted means of XP complementation groups. Despite considerable clinical and biochemical heterogeneity within complementation groups distinctive features emerged. In general, D0, G0, and E0 values of all XP strains investigated, including XP variants, were found to be reduced upon treatment with UV light or N-acetoxy-2-acetylaminofluorene. After treatment with UV light or N-acetoxy-2-acetylaminofluorene, cell strains in which DNA-incising capacity was reduced also showed a similar reduction in both colony-forming ability and DNA repair synthesis. Consequently, the weighted mean D0, G0, and E0 values of XP complementation groups and XP variants correlated with each other. Furthermore, the onset of both early dermatological symptoms of XP and tumor growth correlated with the extent of DNA repair defects. Of 45 XP fibroblast strains checked for colony-forming ability after treatment with methyl methanesulfonate only 3 cell strains from group D were found to be more sensitive than normal controls, suggesting that overall repair in XP strains was equal to that in controls. Weighted means of DNA repair synthesis of XP complementation groups, however, showed reductions hinting at impaired excision of distinct alkylated bases.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany. 205 85

The dynamics of tumor growth of malignant melanoma may be reconstructed by evaluation of suitable private photographs of the patient. Photohistorical investigations can greatly aid in following the course of development of malignant melanomas and show impressively the slow and protracted growth of initial melanomas. We report on a 90-year-old patient with an in situ melanoma (lentigo maligna) and an invasive lentigo maligna melanoma in the facial region. We were able to obtain complete series of photographs from this patient, which show the different development of the two melanomas over a period of more than 30 years. The first tumor to appear developed very slowly while the later one showed invasive growth after a short time period. Development of multiple primary melanomas is a well recognized phenomenon. The presence of multiple primary melanomas does not appear to be a negative prognostic factor. However, patients with primary melanoma should be made aware of increased risk of development another primary and physicians should do careful total body skin examinations for new primary melanomas as well as for recurrences of the original melanoma.
 ...
PMID:[Lentigo maligna and lentigo maligna melanoma of the cheeks. Analysis of different growth patterns via photographic records]. 1769 Aug 16